Drug Interactions between fecal microbiota spores, live and Sulfimycin
This report displays the potential drug interactions for the following 2 drugs:
- fecal microbiota spores, live
- Sulfimycin (erythromycin/sulfisoxazole)
Interactions between your drugs
erythromycin fecal microbiota spores, live
Applies to: Sulfimycin (erythromycin / sulfisoxazole) and fecal microbiota spores, live
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Antibiotics may interfere with the therapeutic effects of oral fecal microbiota, which contains live bacterial spores. The mechanism may be related to the antibiotic inactivating the bacterial spores or reducing bacterial replication. However, the clinical significance of this interaction has not been established.
MANAGEMENT: Concomitant use of oral fecal microbiota spores with antibiotics should generally be avoided. The manufacturer of the oral formulation of fecal microbiota recommends that treatment commence two to four days after completing antibiotic treatment for Clostridium difficile infection.
References
- "Product Information. Vowst (fecal microbiota spores, live)." Aimmune Therapeutics (2023):
sulfiSOXAZOLE fecal microbiota spores, live
Applies to: Sulfimycin (erythromycin / sulfisoxazole) and fecal microbiota spores, live
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Antibiotics may interfere with the therapeutic effects of oral fecal microbiota, which contains live bacterial spores. The mechanism may be related to the antibiotic inactivating the bacterial spores or reducing bacterial replication. However, the clinical significance of this interaction has not been established.
MANAGEMENT: Concomitant use of oral fecal microbiota spores with antibiotics should generally be avoided. The manufacturer of the oral formulation of fecal microbiota recommends that treatment commence two to four days after completing antibiotic treatment for Clostridium difficile infection.
References
- "Product Information. Vowst (fecal microbiota spores, live)." Aimmune Therapeutics (2023):
Drug and food interactions
erythromycin food
Applies to: Sulfimycin (erythromycin / sulfisoxazole)
Food decreases the levels of erythromycin in your body. Take erythromycin on an empty stomach at least 30 minutes before or 2 hours after a meal. This will make it easier for your body to absorb the medication. However, some erythromycin products may be taken without regard to meals. Ask your healthcare provider about your particular prescription if you are uncertain of how to take it. Grapefruits and grapefruit juice may increase erythromycin levels but how this may affect you is not known. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
fecal microbiota spores, live food
Applies to: fecal microbiota spores, live
Consumer information for this interaction is not currently available.
ADJUST DOSING INTERVAL: There are no data regarding the effects of concurrent administration of oral fecal microbiota spores with food.
MANAGEMENT: The manufacturer of the oral formulation of fecal microbiota recommends that patients should have no food or drink except for a small amount of water for at least 8 hours prior to the first dose of fecal microbiota spores. The second and third doses of fecal microbiota spores should be taken on an empty stomach prior to the first meal of the day.
References
- "Product Information. Vowst (fecal microbiota spores, live)." Aimmune Therapeutics (2023):
erythromycin food
Applies to: Sulfimycin (erythromycin / sulfisoxazole)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.